awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38931845-74A6A347-2EB5-4608-B4B9-BF843B291D46
Q38931845-74A6A347-2EB5-4608-B4B9-BF843B291D46
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38931845-74A6A347-2EB5-4608-B4B9-BF843B291D46
What Are We Learning from the FDA-Mandated Cardiovascular Outcome Studies for New Pharmacological Antidiabetic Agents?
P2860
Q38931845-74A6A347-2EB5-4608-B4B9-BF843B291D46
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38931845-74A6A347-2EB5-4608-B4B9-BF843B291D46
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fb2b9688180b817f1b1cb52073e3974d7b8cb2dd
P2860
Effect of bromocriptine-QR (a quick-release formulation of bromocriptine mesylate) on major adverse cardiovascular events in type 2 diabetes subjects.